Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer.
Clinical trial NCT04116775 · UNKNOWN
Trial details
- NCT number
- NCT04116775
- Sponsor
- Julie Graff, MD
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-30
- Primary completion
- 2023-10-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.